DENTAL CARE IMPROVEMENTS USING INFORMATICS AND ARTIFICIAL INTELLIGENCE
Professor Heiko Spallek
Head of School and Dean of The University of Sydney School of Dentistry &
Member of Scientific Advisory Committee, Dentroid
RESEARCHER PROFILE
Filmed in Sydney, Australia | December 2024
Professor Heiko Spallek is the Head of School and Dean of the Sydney Dental School, as well as a member of the Scientific Advisory Committee for Dentroid, a startup in Australia aiming to revolutionise dentistry with laser technology. He has gained extensive experience in various roles at research-intensive institutions across three different continents.
Professor Spallek advanced his dental knowledge by studying computer information science in the US, particularly in Philadelphia. He conducted research for 20 years in the US at the intersection of dentistry and informatics.
As the Dean of Dentistry, he remains involved with a group in the US focused on improving dental care through informatics and artificial intelligence. In Australia, he finds the opportunity to work with Dentroid particularly engaging, as the startup seeks to enhance dental care by eliminating needles and drills to reduce patient discomfort.
Professor Spallek notes that there haven’t been significant changes in dentistry over the past few decades, aside from incremental improvements. He finds it both challenging and interesting to address the stagnation in the field, despite the availability of better materials in dentistry.
He points out that traditional dental treatments still heavily rely on local anaesthesia administered through long needles, as well as high-pitched noises and vibrations from hand pieces, which create discomfort for patients. Furthermore, dentists often have to hunch over patients’ mouths, exposing themselves to infectious spray.
Dentroid is attempting to create a paradigm shift by starting treatments with a light-induced analgesic, followed by a small robot that clamps onto the tooth, removing tissue without the need for drilling through laser technology. This procedure is guided and controlled by the dentist from a desk. Professor Spallek collaborates with researchers from four leading institutions in Australia to bring this new vision to life.
Outside of his professional responsibilities, Professor Spallek prioritises his family and serves as a volunteer director for Community Connections Australia. This organisation offers a range of tailored services to individuals living with disabilities. With the support of a management team, their 150 frontline workers assist approximately 300 clients in achieving greater independence in their homes.
-
Exercise therapy for metabolic dysfunction-associated steatotic liver disease
Dr Shelley Keating is a Senior Lecturer in Clinical Exercise Physiology and Accredited Exercise Physiologist from the School of Human Movement and Nutrition Sciences at the University of Queensland. With a strong grounding in exercise metabolism and body composition, Dr Keating’s research centres on the utility of exercise as a therapy for obesity and related cardiometabolic conditions, notably metabolic dysfunction-associated steatotic liver disease (MASLD).
-
Using Gut Microbes to Reduce Blood Pressure
Professor Francine Marques is an National Health and Medical Research Council Emerging Leader, Viertel Charitable Foundation, and National Heart Foundation Fellow.
She leads the Hypertension Research Laboratory at Monash University and has published more than 120 peer-reviewed papers in journals such as Nature Reviews Cardiology, Nature Medicine, Nature Cardiovascular Research, and Circulation.
-
Personalised approaches to lung therapy
Dr. Adams’ research focus is on lung cancer, which is the deadliest of all cancers worldwide. He is working towards developing personalised approaches to pinpoint a therapy that is going to be most effective for the person with that disease. Dr. Adams’ research is focusing on chemotherapy and targeted therapy, and he is trying to identify upfront which of those tumours are likely to be resistant to the therapy. He then identifies strategies that will resensitize or increase the sensitivity of the tumour to the standard of care that is targeted therapy or chemotherapy.
